Expenses –
One of MindMed’s recent filings laid out how they intend to allocate their funding over the next year or two reasonably well. If you’re looking for this kind of information, you can find the MD&A filing on SEDAR. They also lay out how they anticipate allocating funding from specific offerings to specific programs. It’s a lot of information, but I’m not going to include it here. Quite a few of MindMed’s acquisitions have been predominantly made via the offering of shares, so they haven’t had the same level of cash burning as some of the other emerging companies in the sector. For example:
55 Million Class A shares were offered for their 18-MC program
81,833 Multiple Voting Shares (8,183,300 equivalent) were issued to acquire Health Mode (plus a cash payment of $286,000)
Fair Value of Common Shares: Haven’t been able to find any estimates or projections. If you know of any, just send a message, and this will be updated. The recent offering prices and warrant exercise prices might give you an idea of what investors have been willing to pay for the issued shares.
Offering Close Date Unit Price Warrant Symbol Exercise Price / Date
May 26, 2020 $0.53 CAD MMED.WT $0.79 CAD – May 26, 2022
October 30, 2020 $1.05 CAD MMED.WS $1.40 CAD – October 30, 2023
December 11, 2020 $1.90 CAD MMED.WA $2.45 CAD – December 11, 2023
January 7, 2021 $4.40 CAD MMED.WR $5.75 CAD – January 7, 2024
March 8, 2021 (Private) $3.25 CAD N/A $4.40 CAD – March 9, 2024
News 
Market Data 
Discover 
